A role for the subtypes of CD2 Ig superfamily receptors has been recently demonstrated in eosinophilic inflammation in experimental asthma and atopic asthmatics. We investigated the functions of 284 (CD244) molecules in eosinophil adhesion and chemotaxis, and correlated the results to the pathophysiology of allergic rhinitis (AR). Herein, we show that agonistic stimulation of284 by Ct.?, the anti-human 284 functional grade purified antibody, resulted in significant increase of eosinophils and eosinophil cell line (Eol-I cells) adhesion to collagen type IV, and random migration. These functions were associated with tyrosine kinase phosphorylation of several protein residues of low molecular weight. Flow cytometry (FACS) experiments demonstrated that Eol-l cells, normal peripheral blood eosinophils and eosinophils from AR patients, express surface 284 molecules. /11 vitro AR model demonstrated that the CC-chemokine receptor CCR3 stimulation by eotaxin induced significant increase in the expression of surface 284 in eosinophils and Eol-l cells. Immunofluorescence confocal microscopy images showed that eotaxin induces also redistribution of 284 molecules towards the pseudopods in eosinophils and Eol-l cells, changing their shape. Blocking of 284 molecules by the corresponding neutralizing antibody inhibited eotaxin induced Eol-l-adhesion, chemotaxis and the cytoskeleton changes. Pretreatment of Eo1-1 cells with 1 JiM genistein blocked eotaxin-induced Eol-l adhesion, chemotaxis and 284 up-regulated expression. /11 vivo correlation demonstrated the expression of 2B4 molecules in eosinophils from AR patients to be significantly increased, after nasal provocation challenge. These results identify a novel role for 2B4 molecules in eosinophil functional migratory response and may point to a novel tyrosine kinase-mediated ligation between CCR3 receptor and 284 co-receptor in eosinophil chemotaxis. If so, then 284 molecules would be a novel target for therapeutic modalities in diseases characterized by eosinophilia such as AR.
domain in its extracellular region and several tyrosinebased intracellular motifs. In humans, 28 4 is expressed in several haemopoietic cells including NK cells, T lymphocytes especially CD8+ T cells as well as subsets of basophils, monocytes and eosinophils (6, (8) (9) (10) (11) (12) . Recently, reports have demonstrated a role for C02 in eosinophilic inflammation in experimental asthma and from atopic asthmatics (13) (14) (15) . Nonetheless, little is known about the role of these novel molecules in eosinophil recruitment and the pathophysiology ofAR.
Hypereosinophilia with tissue infiltration is involved in a wide spectrum of immunological conditions such as allergic inflammation, parasiti c infections, hypereosinoph il syndrome (HES) and chronic eosinophilic leukemia (CEL).
Eotaxin, which binds only to the seven-transmembrane Gprotein-coupled receptor CC R3 abundantly expre ssed on eosinophils, possesses the highest selectivity to eos inophils in controlling ce ll migration amon g the eos inophil chemoattractants (16) (17) (18) (19) . In addition to the well reported roles of eotaxin in allergic airways eosinophilic inflamm ation , a role for it in environmental interaction to microorganisms in inducing or exaggerating eosinophilic inflammation in chronic rhino sinusitis (20) , and in chron ic leukemia , has been also sugges ted (2 1-22) . Although reports on the signal transduction of eotaxin involved in recruiting eosinoph ils are well characterized, to the best ofom knowledge no single study has investigated the role of2B4 as effector co-stimulatory molecules in eosinophil recruitment agains t eotaxin.
Eol-l is an ideal cell line to study cellul ar proteins and the ability of n-butyrate to induce Eol -I differentiation to mature eosinophils make the cell line also ideal for the study of alIergic inflammation in diseases such as AR and asthma . Accordingly, the current in-vitro mod el was designed to study the expression, regulation and migrat ory functional role s of 28 4 molecules in eotaxi n-induced eosinophil recru itment utilizing eosi no phils and Eol-l ce lls. An in-vivo investigation by alIergen nasal provocation was also performed, to correlate the biochemical result s to a more clini cal application.
MATERI AL S AN D METHODS

Cell preparation
Eosinophils and NK ce lls were isolated by Percoll (66% ) solution separation. Eosino phils and NK cell s were further pur ified by negative selection immunomagnetic cell separation (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany), using anti-C D16 magnetic beads for eosi nophil puri fication and a coc ktail of biotin-conjugated antibodies again st lineage-specific antigens and a coc ktail of microbeads (N K Cell Isolation Kit-human, Miltenyi Biotec, Bergisch Gladbach, Germany) for N K (C D56+ve CD3 -ve) cells purific ation.
£ OL-1 cell line
Human eosin ophili c leukem ia (Eol-l) cell line (Riken BioRes ource Center, Japan) was used in the current biochemical study. Cell differentiation into matu re eosinophils was induced by histone deacetylase inhibitors, n-butyrate precisely as described earlier (23) . Succes sful differentiation was confirm ed by morphological changes and cell viability by trypan blue that was always >98%.
2B4 antibodies
Two anti-2B4 antibodies were tested on hum an eos inophils and Eol-1 ce lls: Antago nistic anti-2B4 antibody (R& D systems) and agonistic C1. 7 the antihuman 2B4 function al grade purified (eBiosc ience) . As for the FACS and confocal microscopy experiment s, two conj ugated antib odies wer e used that gave similar results: conj ugated PE anti-human 2B4 antibody (Biolege nd) and conjugated -FITC anti-2B4 antibody (R&D systems).
Adhesion assay
Eol-1 at conc entration of 2X ]06cells/ml (unless stated otherw ise) or eosi nophils at Ix l O' vml were primed for I h with 100ng/ml eotaxin or buffer, followed by two washes with buffer saline. Then 30~I of Eol-1 suspension were placed in I is-Sli de VI coated (coIlagen IV) ce ll microscopy chamber (lbidi integrated BioDiagnostics, Munich-Germany) and left to adhere for I h. After two was hes, adherent cell s were fixed with cold meth anol and conserved in Prol.ong" Gold anti fade with DAPI (Invitrogen Molecular Probes Eugene Oregon, USA ). Cells were then counted under microscopy (magnification x20). As for blockin g experi ments, the Eol-1 ceIls were pretreated with: buffer, I0 ug/ml irrelevant block ing antibody (isotype), I, 5 & I0 ug/rnl anti-human 2B4 antibody (R&D systems) or I~M Geni stein (Sig ma) befor e stimulation for I h with 100ng/ml eota xin .
Chemotaxis assay
Chemotaxis assays were performed in triplicate in a 48-weIl microchemotaxis Boyden chamber incubated in 5% C02 at 37°C for 90 min. Aliquots of 29~I of the chemotactic agent eotaxin (R&D Systems; Minneapolis, MN, USA) at 100ng/ml or buffer were placed in the lower weIls and 50 ul of Eol-1 or eosinophils suspen sion ( l O'cells/ml) were placed in the upp er we lls. The two chamb ers were se parated by a 5.0 urn pore polycarbonate membrane (Nuc1epore, Whatm an, Middl esex, UK). Migrated cell s adherent to the lower surface were co unted in 5 selected high power fields/well under a light micro scope (5hpf; x400). For blockin g experiments, the Eol-1 cells were pretreated with: buffer, 10 ug/rnl irre levant blockin g antib ody (iso type), I, 5 & 10 !-Igi ml anti-human 28 4 antibody (R&D sys tems) orl !-1M Gen istein (Sigma), for 60 min at 37°C. Cell s we re then was hed twice, their viabil ity were reche cked by trypan blue that was unch anged dur ing the incubation peri od , and was always>9 8%. Cells were re-su spended in buffer medium and their chemotaxis was checked as stated above.
Western blot
Western blot analys es for .tyro sine kinase protein res idues was performed from whole cellular extract from peripheral blood eosinoph ils and Eol-1 cells utilizing antiphosph otyrosine 4G I Ow(Upsa te-CA/Mi llipore).
Conf ocal microscope images
30 !-II of cell suspe nsio ns at a concentration of 10 6 cells/ ml were placed in I !-I-Slide V I coa ted (collagen IV) ce ll micro scopy chamb er (lbidi integrated BioDi agnostics, Munich-Ge rmany) and left to adhere for I h. Aft er tw o washes, stimulation with either buffer or eotax in 100nglml we re then perform ed for I and 15 minutes. For blo ckin g exp erim ent s, adh ered ce lls were incubated for 30 min with l Oug/ml anti-human 2B4 before being stimulated with 100ng/ml eotaxin. A fter two additional washes with PBS the cells were fixed with 4% formaldehyde for 20 min s and Nomarski-differenti al interference images were obtained using confocal microscopy (Leica TCS SP2 ). For immunofluoresence images, fixed cells were stain ed with conjugated PE anti-human 2B4 antibody (Biolegend) or Alexa fluor 488 ®-Phalloidin diluted 40x (Invitrogen Molecular probes") for I h in the dark , on ice, was hed twice with PBS and analyze d by confocal microscopy.
Fluorescence-activated cell sorting analysis
2B4 surface expression on NK cells, eosinophils and Eol-l we re anal ysed by FACS (FACS CANTO II BD Systems) as reported previou sly (24) . Briefly, stimulated or unstimulated cells were fixed with 4% paraformaldehyde for 15 minutes. Th e cells were then was hed and incub ated with the corresponding antibody (surface expression) or perm eabili sed by 0.1% saponin (total ex press ion) and then incubated with A lexa fluor 488 ' 10 -Phalloidin dilu ted 40x (Invitrogen Molecular probes"), for 60 min s in the dark , on ice. After two additional washes, cell s were conserved in paraformaldehyd e I% and then ana lysed for their fluorescence intensity.
Sta tistical analys is
Statistical significance was performed by paired r-test and AN OVA. Values of P<0.05 were cons idered significant.
RESULTS
Effects of 2B4 antibodies on eosinophil and Eol-I adhesion and random migration
Two anti-284 antibodies were tested on hum an eos inophils and Eol-1 ce lls: anti-2B4 antibody (R&D systems) and Cl.7 the anti-human 2B4 functional grade purified (eBioscienc e). The former activated neither the random migration, spontaneous adhesion nor protein phosphorylation of tyrosine kinase residu es in eosinophils or Eol-1 cells. However, the latter increased random migration, spontaneous adhes ion and the phospho rylation of several tyrosin e kina se residues in eosinophils and Eol-1 (Table I, Fig.  I A) . Similarly, Cl.7 but not anti-2B4Ab induc ed cell shape changes and F-actin reorganization (data not shown). Accordingly, anti-2B4 antibody (R& D systems) was used as neutr alizing antibody in the follow ing experiments. Of note, the incre ased random migration and aggregations of cells in respon se to C 1.7 was blocked by Genistein ( Fig. IB , compares representative photo s of migrated Eol-I cells to 5.0 urn pore polycarbonate membranes). Genistein alone reduc ed neither the spontaneous adhesion nor random migration (data not shown). Thi s indicates that the ago nistic stimulation of 284 induced increase in eos inophils adhesion and random migration is mediated by tyro sine kinase activity.
Surface exp ression of2B4 receptor
NK cells abundantl y express 2B4 receptor and therefore serve as our pos itive control cell s. Fig.  2 demonstrates that the surface express ion of 284 by NK cells was much higher and abundant than eosinophils from health y subj ects and Eol-1 cells. However, stimul ation of eosinophils from healthy subj ects and Eol-1 cells, by the optimal dose of IOOng/ml eota xin, result ed in significant CCR3 mediated up-regulati on of surface 2B4 mol ecul es. The confocal microscopy images in Fig. 3A and 8 demonstrate that the novel up-regulated surface expression of 28 4 (in red) in eosinophils and Eol-1 rapid increase in the F-actin contents and its intracellular organization that is linked to eosinophil shape changes (25) . In Fig. 4 (I) we demonstrate that IOOng/ml stimulation of Eol-I resulted in similar F-actin reorgani zation and shape chan ges . Interestingly, blockage of 2B4 by 10 ug/ml of the corresponding neutralizing antibody resulted in blockage of both the F-actin increase contents, reorganization and the cell shape changes. 284 Ab treatment did not induce e ither apoptosis or necrosis in Eol-I cells as judged by FACS analys is util izing PE Annexin V and 7AAD; BD 8ioscience (data not shown). Of note, 284 irrelative antibody (isotype) did not mo dify eotaxin-induced cell shape changes and F-actin contents and reorganization. The mean fluorescence intensity (MFI) for F-actin was 13±2 for the buffer stimulation, 13.8±5 for eota xin stimulation and I3 .05±3 for eot axin stimulation in presen ce of 284 Ab.
The signal transduction is a fast event that takes place after the ligand stimulates its specific receptor on the cell surface. Therefore, we next double stained Eol-I cell s with Phalloidin and anti-284 Ab to inve stigate the co-localiz ation of these mol ecul es after I min stimulation by IOOn g/ml eotaxin. As can be seen in Fig. 4 (II) , there was a fast reorganization and co-localization of these molecules at as earl y as I min stimulation of CCR3.
Taken collectively, the results presented in Figs . 3 and 4 strongly indicate a co-stimulatory role for 284 with CCR3-induced cytoskeleton changes. As cytoskeletal elements and shape changes are prerequisites for cell migration, we hypothesize that 2B4 are important co-stimulatory molecules for eotaxin-induced eosinophil chemotaxis. Accordingly, the foll ow ing migratory functional assays were performed.
A.E. EL·S HAZLY ET AL. X-tubilin B cells was accompanied by 2B4 reorganization w ithin pseudopods. These results pointed to a close rel ation bet ween cytoskeletal elem ents , shape changes and 2B4 .
Involvement of 2B4 in F-actin reorganization and £ 01-1 cells shape changes
We earlier reported that eotaxin induces a (25) (26) . Therefore we next, tested the ability of genistein, a tyrosine kinase inh ibitor, A N<CElis Ernrq:hls in modulating eotaxin-induced Eol-l adhesion and chemotaxis. Equal concentration of Eol-l cells (1 x 10 6 cells Iml) was pretreated with genistein for 1 h before their stimulation with eotaxin. As seen in Fig. 6A and B, 1 uM concentration of genistein blocked both eotaxin-induced Eol-l adhesion and chemotaxis. These results indicate the involvement of 2B4 and tyrosine kinase, in eotaxin-induced Eol-1 adhesion and chemotaxis signal transduction.
Involvement of 2B4 in £ 01-1 adhesion and chemotaxis is tyrosine kinase-dependent
Eotaxin-induced 2B4 up-regulated expression by Eol-I is tyrosine kinase-dependent
Experiments were performed to investigate whether the eotaxin-induced 2B4 up-regulated expression is a downstream event to tyrosine kinase activity or through independent pathway. Eol-1 cells were incubated with 1 )..lM genistein before being stimulated with 100 nglml eotaxin. In Fig. 6C , FACS analysis shows that the up-regulated expression of 2B4 in Eol-l by eotaxin was blocked by genistein. These results may indicate that phosphorylation of multiple intracellular tyrosine protein residues by CCR3 stimulation is an important upstream event for the co-stimulatory effects of 2B4 in Eol-1 migratory functional response by eotaxin.
Up-regulation of 2B4 in eosinophils from allergic rhinitis patients
Finally, to have an idea of the effect of 2B4 molecules in the pathophysiology of AR and to validate our cellular and molecular results, we performed nasal provocation challenge with HOM allergen on 8 patients sensitized against HOM. These patients reported nasal allergic symptoms consistent with HOM allergen and their skin prick tests confirmed positive results to HOM allergen
Fig. 3. Confocal images of (A) Eol-I cells and (B) peripheral blood eosinophils, showing the relationship ofcell shape changes and the up-regulated expression of 2B4 (red) in cells treated with 100ng/ml eotaxin. Images are of one experiment representative of 3. Note the peripheral and membrane bound distribution of2B4.
Eot.-clfl EoI.&Il" 1'l -as well as the allergosorbant test (RAST). None of them had previously taken antihistamines or nasall systemic cortisone. After obtaining their consent, the allergen provocation was induced by blotting paper discs soaked with either the diluent only or the allergen dilution (Stallergenes 1001R/ml) in contact with the mucosa of the inferior turbinate. Non-specific responsiveness was always eliminated before each challenge by introducing the paper disc in contact with the inferior turbinate mucosa. The patients' vital signs were monitored for at least 30 min after challenge. The patients' peripheral blood eosinophils were purified and analyzed by FACS for their expression of2B4 before challenge and at 6 and 24 h post challenge. Two patients served as control and were challenged with diluent only. They did not show changes in 2B4 expression after challenge. 
or (iv) eotaxin IOOng/ml after pretreatment of cells with IOjlg/ml anti-2B4 Ab for 30 min. A) Green represents F-actin of images -of group of cells from the same slide (I PF, magnification x20). B) One cell representative of the group ofcells in panel (A) (magnification x40). C) Nomarski-differential interference images. Results are of one experiment representative of 6 independent experiments all showing similar results. (II) Stimulation is with 100ng/ml eotaxin for I min. Grey arrows point to co-localisation of F-actin (in green) and 2B4 (in red).
On the other hand, as demonstrated in Fig. 7 A, C and 0, in patients who were challenged with HOM allergen their pre-challenge expression of surface 2B4 was expressed on 28±5% of cells with MFI of 44.4±7.1. Interestingly, 6 h after challenge, 2B4 surface expression increase to 50±7% with MFI These results indicate the involvement of these molecules in the pathophysiology of AR and further support and validate the results of our biochemical migratory assays. Furthermore, the involvement of 2B4 in the pathophysiology of AR seems to be specific to eosinophils, since comparative study on NK cells from the same patients neither modulated the number of cells expressing 2B4 nor 2B4 MFI, before challenge and 6 h post-challenge ( Fig. 7A ). Furthermore, confocal images taken directly from eosinophils adherent to collagen IV coated slides ( Fig. 7B ) also demonstrated increased fluorescence intensity of 2B4 after challenge with increase in cytoskeleton changes. This further supports a possible role for 2B4 in the pathophysiology of AR.
DISCUSSION
The migratory function of eosinophil 2B4 molecules is not yet fully elucidated. We observed that the stimulation of eosinophils from AR patients and Eol-I cells by Cl.7 the agonistic monoclonal Ab leads to tyrosine phosphorylation and an increase in spontaneous adhesion and random migration of eosinophils. This is attributed to the functional ability of C 1.7 Ab to share with CD48 the involvement to the same residue in the V domain of human 2B4. This provides a novel role for CD48-2B4 molecules in eosinophil adhesion and chemotaxis through tyrosine kinase cascade.
To further elaborate on the possible role of2B4 in chemokine-directed eosinophil migration, we next investigated the possible ligation of CCR3 receptors to 2B4 molecules utilizing the potent and relatively specific eosinophil cc-chemokine eotaxin and Eol-1 cells. This cell line was ideal for the in-vitro migratory assays, especially FACS analysis and confocal images which showed that eosinophils and Eol-I express surface 2B4 in a similar fashion. Cell migration is preceded by several complex biochemical events including adhesion, protein kinase activity and actin cytoskeletal re-organization and cell shape changes (28) . These events have been speculated to be linked to co-stimulatory transmembrane molecules, such as integrins, that have the ability to bind through their intracytoplasmic tail to filamins, the large, actincross-linking proteins that connect transmembrane signaling molecules to the cytoskeleton (29) . Herein, our results support this hypothesis since the transmembrane molecules 2B4 were molecularly linked to F-actin reorganization and cytoskeleton changes. Interestingly, 2B4 expression and cytoskeleton changes were blocked by genistein, a tyrosine kinase inhibitor. This confirms our previous observation that HCK and c-Fgr, the Src family kinases, are involved in eotaxin-induced eosinophil chemotaxis (25) . To this end, signal transduction through 2B4 in activated NK cells has been shown to be linked to phosphorylation of tyrosine motifs in its cytoplasmic tail and to the recruitment of SAP and the Src family kinase Fyn (30) (31) . Furthermore, we demonstrate that stimulation of eosinophils from AR patients and Eol-1 cells by C 1.7 leads to tyrosine phosphorylation of several low molecular weight proteins in eosinophils and Eol-1.
It is then possible that following CCR3 stimulation on the surface of eosinophils by eotaxin, a co-receptor stimulation via 2B4 helped by the physical association of Hck and c-Fgr and possibly others to CCR3 in a compartment fashion triggers signal transduction through tyrosine phosphorylation. Taken collectively, our biochemical assays demonstrate that 2B4 co-stimulatory receptor is functional and involves adhesion, cytoskeletal changes and chemotaxis against eotaxin.
Single nasal antigen challenge provokes immediate anaphylactic reaction in nasal mucosa within 5-15 minutes, and the duration may last for less than 1 hour. The symptoms, mainly nasal obstruction, reappear 6-8 hours after antigen challenge. This phenomenon is called late phase reaction of allergic rhinitis and is characterized by eosinophil recruitment, which can last up to 24-48 hours (very late reaction). In this study, we show that HDM nasal challenge in patients with AR to HDM resulted in up-regulation of the expression of 2B4 in the peripheral blood eosinophils of these patients. This up-regulation lasted up to 24 hours post-challenge. This may indicate the involvement of 2B4 molecules in the pathophysiology of AR and support their novel role(s) in eosinophil activation and recruitment. However, due to the involvement of many in-vivo mediators in the pathophysiology ofAR, it is difficult to say which mediator(s) is specifically involved in this up-regulation. Nonetheless eotaxin remain one of these important allergic mediators.
In conclusion, therapeutic modalities aiming at targeting either the CCR3/2B4 receptors and/or the tyrosine kinase intracellular activity would be a suitable target for allergic airway eosinophilic inflammation.
